7 results
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
SideEffects #Table #DecisionAid ... #Orals #DM2 #Diabetes ... Endocrinology #Pharmacology ... #Management
Diabetes Medication Choice
-Diabetes Medication Choice decision aid cards provide information on medications commonly used to treat
metformin, SGLT-i, GLP1 ... images/2507 #Management ... #DM2 #PatientInfo ... #DecisionAid #Medications ... Reduction #Costs #Pharmacology
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Sulfonylureas GLP ... agonists - ↓ major adverse ... table #comparison #management ... endocrinology #dm2
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
- Pharmacology ... semaglutide variety of adverse ... Receptor #Agonists #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
Side Effects of Atypical and Typical Antipsychotics - Comparison Table
Atypical antipsychotics: Risperidone, Quetiapine, Olanzapine, Amisulpride, Ziprasidone
, dose related adverse ... development of diabetes ... Comparison #Table #Psychiatry ... #Pharmacology # ... DecisionAid
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
Management 1 ... INCRETIN AGENTS • GLP ... - Prevents GLP ... #Management #pharmacology ... #DM2 #DMII #Classification
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Increase Incretins (GLP-I ... Renal #Dosing #Pharmacology ... #Management #Diabetes ... #DM2 #Endocrinology